SCHEMBL7325150

SCHEMBL7325150

Cc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2ccc(OCCN(C)C)cc2)C(=O)O)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGA4 P13612 4/20 0.60
ITGB1 P05556 6/20 0.57
ITGA5 P08648 3/20 0.57
ITGB7 P26010 1/20 0.52
ALDH1A1 P00352 1/20 0.51
ITGAV P06756 1/20 0.50
KMT2A Q03164 1/20 0.48
ITGA2 P17301 1/20 0.47
FKBP1A P62942 2/20 0.47
MMP1 P03956 1/20 0.47
ADAM17 P78536 1/20 0.47
GAA P10253 1/20 0.46
HPGD P15428 1/20 0.46
KCNQ1 P51787 1/20 0.46
MAPT P10636 1/20 0.45
TSHR P16473 2/20 0.45
MAPK1 P28482 1/20 0.45
HCRTR1 O43613 1/20 0.45
HCRTR2 O43614 1/20 0.45
CYP3A4 P08684 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7315770 0.96 ITGA4 (0.59) ITGA4ITGB1ITGA5ITGB7ALDH1A1
SCHEMBL7319858 0.93 ITGA4 (0.59) ITGA4ITGB1ITGA5ITGB7ALDH1A1
SCHEMBL7322201 0.92 ITGA4 (0.60) ITGA4ITGB1ITGA5ITGB7ALDH1A1
SCHEMBL6708307 0.90 ITGB1 (0.57) ITGA4ITGB1ITGA5ITGB7ALDH1A1
SCHEMBL7318203 0.90 ITGA4 (0.60) ITGA4ITGB1ITGA5ITGB7ALDH1A1
SCHEMBL7073204 0.89 ITGB1 (0.60) ITGA4ITGB1ITGA5ITGB7ALDH1A1
SCHEMBL7319464 0.89 ITGA4 (0.53) ITGA4ITGB1ITGA5KMT2AFKBP1A
SCHEMBL7314294 0.89 ITGA4 (0.66) ITGA4ITGB1ITGA5ITGB7ALDH1A1
SCHEMBL7323424 0.89 ITGB1 (0.56) ITGA4ITGB1ITGA5ITGB7ALDH1A1
SCHEMBL7323451 0.88 ITGA4 (0.63) ITGA4ITGB1ITGA5ITGB7ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6492421-B1 BINDING VERY LATE ANTIGEN-4; INFLAMMATORY DISEASES SUCH AS ASTHMA, ALZHEIMER'S DISEASE, ATHEROSCLEROSIS, AIDS, DEMENTIA, DIABETES, INFLAMMATORY BOWEL DISEASE, RHEUMATOID ARTHRITIS, TISSUE TRANSPLANTATION, TUMOR METASTASIS, MYOCARDIAL ISCHEMIA ATHENA NEUROSCIENCES, INC. 2002-12-10 US claimed
US-6492421-B1 BINDING VERY LATE ANTIGEN-4; INFLAMMATORY DISEASES SUCH AS ASTHMA, ALZHEIMER'S DISEASE, ATHEROSCLEROSIS, AIDS, DEMENTIA, DIABETES, INFLAMMATORY BOWEL DISEASE, RHEUMATOID ARTHRITIS, TISSUE TRANSPLANTATION, TUMOR METASTASIS, MYOCARDIAL ISCHEMIA ATHENA NEUROSCIENCES, INC. 2002-12-10 US disclosed
EP-1001972-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-05-24 EP disclosed
WO-1999006431-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 WO disclosed